Edward J. Benz Jr., MD, the longest-serving chief executive at Dana-Farber Cancer Institute in Boston, has announced that he will leave the job in June 2016, a month after he turns 70, according to The Boston Globe.
Dr. Benz has been part of a number of accomplishments at the institute. Under his tenure, fundraising at Dana-Farber grew to more than $200 million annually from a network of 300,000 donors, the number of patients seeking treatment at Dana-Farber tripled and revenues climbed from $265 million to more than $1 billion, according to the report.
Dr. Benz became the president and CEO of the cancer institute in 2000. Before assuming the presidency of the institute, he served as chairman of the Department of Medicine at the Johns Hopkins University School of Medicine and the Sir William Osler Professor of Medicine.
According to the report, Dr. Benz, a hematologist, plans to continue his research and his teaching role at Harvard Medical School after he retires.
More articles on executive moves:
Rare Genomics Institute announces new director and CEO